T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
15 nov. 2023 02h00 HE
|
T-Therapeutics
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis...